MedTrace Logo

Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms

NCT07272681 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-16

No results posted yet for this study

Summary

This study aims to evaluate the effect of Helicobacter pylori eradication on gastrointestinal symptoms in adult patients. H. pylori infection is a common cause of dyspepsia and other upper gastrointestinal complaints. The trial will assess whether successful eradication therapy leads to significant improvement in symptoms compared to baseline. Adult patients diagnosed with H. pylori infection will receive standard eradication treatment, and symptom changes will be monitored using validated questionnaires over a defined follow-up period.

Conditions

  • Helicobacter Pylori Infection
  • Dyspepsia
  • Gastrointestinal Symptoms

Sponsors & Collaborators

  • Amany Usama Ahmed Arafa

    lead OTHER

Principal Investigators

  • Amany Usama · Department of Gastroenterology and Tropical medicine Sohag University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-20
Primary Completion
2026-06-20
Completion
2026-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07272681 on ClinicalTrials.gov